Neutral
Pacira BioSciences Inc. (PCRX) Stock Rises on Q4 2025 Earnings
Pacira BioSciences Inc. (PCRX) announced its Q4 2025 earnings, reporting a revenue of $196.9 million, exceeding estimates, while diluted EPS was $0.04...
PCRX
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (0)
Latest PCRX News
Neutral
Research PCRX on:
Ad Space